It took years and featured a number of delays, but WestRock (WRK) finally completed the spinoff of its specialty chemicals business, Ingevity (NGVT). The new company began trading on the NYSE today and shareholders should have received one share of NGVT for every six shares of WRK owned. As usual, executives are excited about the future prospects and here… Read More »
After delaying the spinoff of its chemical business due to ‘complexities’, WestRock (WRK) is finally ready to complete the spinoff of Ingevity. The transaction is expected to be completed on May 15th, with WestRock shareholders receiving 1 share of the Ingevity for every 6 WestRock shares owned. The new company will trade on the NYSE under the ticker… Read More »
Wall Street loves spinoffs, but these transactions are hardly simple affairs to execute. There is a reason most of them take more than 9 months to consummate. After pushing off the expected completion date of Ingevity’s spinoff again, it seems WestRock (WRK) is learning that fact the hard way. The specialty chemical spinoff is now expected to be… Read More »